The BMSC+VEGF group had decreased collagen deposition, reduced stellate cell activation, and decreased TGFβ and IL-6 expression (inflammation marker), which further suggests that combination of VEGF treatment and BMSC transplant drastically reduces liver fibrosis. This evidence concerns the gene TGFB1 and Hepatic fibrosis.